Who, What, and When: Managing Hyperimmune Response in Patients Hospitalized for COVID-19 Infection

CME: 0.75

Target Audience

This initiative has been designed to address the educational needs of clinicians involved in the care of patients with COVID-19 in the hospital setting, including those specializing in infectious disease, critical care medicine, emergency medicine, and pulmonology. It may also benefit primary care physicians, hospitalists, and other allied healthcare providers who are interested or involved in the care of patients with COVID-19.

Program Overview

This interactive infographic activity provides an overview of the cytokine storm and clinical trial data for immunomodulating agents to treat patients hospitalized with severe COVID.

Learning Objectives

Upon completion of this activity, participants should be better able to:

  • Outline the progression of the hyperimmune response in COVID-19 infection
  • Summarize outcomes of clinical trials to treat patients with cytokine storm resulting from COVID-19 infection

Post a comment to this article